Performance and clinical decision-making using the prognostic 40-gene expression profile (40-GEP) test in 1,018 patients with high-risk cutaneous squamous cell carcinoma (SCC). J of Skin. 2022;6(6):s96. doi:10.25251/skin.6.supp.96